Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-05-03 4:57 pm Sale | 2021-04-26 | 13D | Aligos Therapeutics, Inc. ALGS | Versant Venture Capital VI, L.P. | 77,757 5.100% | -19,439 (-20.00%) | Filing History |
| 2021-02-16 4:27 pm Purchase | 2020-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | HHLR Advisors, Ltd. | 86,603 5.700% | 86,603 (New Position) | Filing History |
| 2021-02-16 07:03 am Purchase | 2020-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | ROCHE FINANCE LTD | 123,694 8.100% | 123,694 (New Position) | Filing History |
| 2021-02-11 4:18 pm Purchase | 2020-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | BLATT LAWRENCE | 95,875 6.700% | 95,875 (New Position) | Filing History |
| 2021-02-11 4:16 pm Purchase | 2020-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | Beigelman Leonid | 71,894 5.100% | 71,894 (New Position) | Filing History |
| 2021-01-11 09:10 am Purchase | 2020-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | WELLINGTON MANAGEMENT GROUP LLP | 157,104 10.300% | 157,104 (New Position) | Filing History |
| 2020-10-30 4:25 pm Purchase | 2020-10-20 | 13D | Aligos Therapeutics, Inc. ALGS | Versant Venture Capital VI, L.P. | 97,196 7.200% | 97,196 (New Position) | Filing History |
| 2020-10-28 4:30 pm Purchase | 2020-10-20 | 13G | Aligos Therapeutics, Inc. ALGS | Vivo Capital VIII LLC | 141,881 10.500% | 141,881 (New Position) | Filing History |
| 2020-10-22 4:31 pm Purchase | 2020-10-15 | 13D | Aligos Therapeutics, Inc. ALGS | Novo A/S | 104,583 7.700% | 104,583 (New Position) | Filing History |
| 2020-10-22 10:01 am Purchase | 2020-10-12 | 13G | Aligos Therapeutics, Inc. ALGS | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 76,248 5.340% | 76,248 (New Position) | Filing |